Kovitz Investment Group Partners LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,245 shares of the company's stock, valued at approximately $1,343,000.
A number of other hedge funds also recently added to or reduced their stakes in the company. Insight Folios Inc increased its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock worth $358,000 after purchasing an additional 63 shares in the last quarter. Fiduciary Group LLC increased its holdings in Clorox by 0.4% in the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company's stock worth $2,600,000 after buying an additional 72 shares in the last quarter. GHP Investment Advisors Inc. lifted its stake in Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company's stock valued at $496,000 after acquiring an additional 72 shares during the period. SPC Financial Inc. boosted its holdings in shares of Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company's stock valued at $476,000 after acquiring an additional 75 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its stake in shares of Clorox by 17.2% in the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock worth $83,000 after acquiring an additional 75 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts recently issued reports on the stock. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a report on Monday, October 14th. Barclays upped their price objective on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research report on Friday, November 1st. BNP Paribas raised Clorox to a "strong sell" rating in a research report on Friday, September 6th. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research report on Friday, October 11th. Finally, Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Five research analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $155.00.
View Our Latest Stock Report on Clorox
Shares of CLX stock opened at $167.73 on Wednesday. The stock has a fifty day simple moving average of $163.59 and a two-hundred day simple moving average of $150.86. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The firm has a market capitalization of $20.76 billion, a PE ratio of 58.44, a PEG ratio of 3.08 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.
Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter last year, the business posted $0.49 earnings per share. The firm's revenue was up 27.0% on a year-over-year basis. On average, analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. Clorox's dividend payout ratio is 170.04%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.